KR101006556B1 - Anti-bacterial compositions against Streptococcus - Google Patents
Anti-bacterial compositions against Streptococcus Download PDFInfo
- Publication number
- KR101006556B1 KR101006556B1 KR1020070134699A KR20070134699A KR101006556B1 KR 101006556 B1 KR101006556 B1 KR 101006556B1 KR 1020070134699 A KR1020070134699 A KR 1020070134699A KR 20070134699 A KR20070134699 A KR 20070134699A KR 101006556 B1 KR101006556 B1 KR 101006556B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- streptococcus
- spectral
- thyme
- fish
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 241000194017 Streptococcus Species 0.000 title claims abstract description 21
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 19
- 239000000284 extract Substances 0.000 claims abstract description 75
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 41
- 240000002657 Thymus vulgaris Species 0.000 claims abstract description 34
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 34
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 34
- 230000003595 spectral effect Effects 0.000 claims abstract description 27
- 241000251468 Actinopterygii Species 0.000 claims abstract description 24
- 239000000419 plant extract Substances 0.000 claims abstract description 10
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 abstract description 19
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 19
- 235000008434 ginseng Nutrition 0.000 abstract description 19
- 241000894006 Bacteria Species 0.000 abstract description 18
- 239000003242 anti bacterial agent Substances 0.000 abstract description 14
- 229940088710 antibiotic agent Drugs 0.000 abstract description 12
- 208000035143 Bacterial infection Diseases 0.000 abstract description 8
- 239000004599 antimicrobial Substances 0.000 abstract description 7
- 241000393483 Dryopteris crassirhizoma Species 0.000 abstract description 4
- 239000013505 freshwater Substances 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 239000013535 sea water Substances 0.000 abstract description 4
- 241000246044 Sophora flavescens Species 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 235000019688 fish Nutrition 0.000 description 22
- 239000000341 volatile oil Substances 0.000 description 18
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 241000894007 species Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 229960000723 ampicillin Drugs 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 235000020710 ginseng extract Nutrition 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000013272 agar well diffusion method Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 208000022362 bacterial infectious disease Diseases 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000010678 thyme oil Substances 0.000 description 5
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 4
- 238000009360 aquaculture Methods 0.000 description 4
- 244000144974 aquaculture Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000009036 growth inhibition Effects 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000277331 Salmonidae Species 0.000 description 3
- 241000194022 Streptococcus sp. Species 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 208000010824 fish disease Diseases 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000005445 natural material Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 241000723298 Dicentrarchus labrax Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000269908 Platichthys flesus Species 0.000 description 2
- VQYBAEAOOJBSTR-QHSBEEBCSA-N Sophoranol Chemical compound C([C@@H]12)CCC(=O)N1C[C@@]1(O)[C@H]3[C@@H]2CCCN3CCC1 VQYBAEAOOJBSTR-QHSBEEBCSA-N 0.000 description 2
- VQYBAEAOOJBSTR-AYRXBEOTSA-N Sophoranol Natural products O=C1N2[C@H]([C@@H]3[C@@H]4[C@](O)(C2)CCCN4CCC3)CCC1 VQYBAEAOOJBSTR-AYRXBEOTSA-N 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- 241000194056 Streptococcus iniae Species 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000000077 insect repellent Substances 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229930015582 oxymatrine Natural products 0.000 description 2
- -1 painkiller Substances 0.000 description 2
- 238000009372 pisciculture Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical compound CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- ZSBXGIUJOOQZMP-BHPKHCPMSA-N sophoridine Chemical compound C1CC[C@@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-BHPKHCPMSA-N 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 2
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- 241000881711 Acipenser sturio Species 0.000 description 1
- 241000252087 Anguilla japonica Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000194039 Lactococcus piscium Species 0.000 description 1
- 241000489982 Lagodon rhomboides Species 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100030417 Matrilysin Human genes 0.000 description 1
- 108090000855 Matrilysin Proteins 0.000 description 1
- NLSTZAFFNDSJGQ-UHFFFAOYSA-N Matrin Natural products O=C1CCCN2CC3CCNC4CCCC(C34)C12 NLSTZAFFNDSJGQ-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 241001502129 Mullus Species 0.000 description 1
- 244000265736 Nelumbo pentapetala Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241001137910 Notemigonus crysoleucas Species 0.000 description 1
- 241000269982 Paralichthys Species 0.000 description 1
- 241000157468 Reinhardtius hippoglossoides Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241001464947 Streptococcus milleri Species 0.000 description 1
- 241000194055 Streptococcus parauberis Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000207194 Vagococcus Species 0.000 description 1
- 241000207192 Vagococcus salmoninarum Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 229960004484 carbachol Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- JBIWCJUYHHGXTC-AKNGSSGZSA-N doxycycline Chemical compound O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O JBIWCJUYHHGXTC-AKNGSSGZSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960003760 florfenicol Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009920 food preservation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/20—Fabaceae or Leguminosae [Pea or Legume family], e.g. pea, lentil, soybean, clover, acacia, honey locust, derris or millettia
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K61/00—Culture of aquatic animals
- A01K61/10—Culture of aquatic animals of fish
- A01K61/13—Prevention or treatment of fish diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/04—Pteridophyta [fern allies]; Filicophyta [ferns]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
- A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N2300/00—Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Agronomy & Crop Science (AREA)
- Medicinal Chemistry (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
본 발명은 고삼 추출물, 관중 추출물 및 타임 추출물로 이루어진 군으로부터 선택된 1종 이상의 식물 추출물을 포함하는 항균용 조성물에 관한 것이다.The present invention relates to an antimicrobial composition comprising at least one plant extract selected from the group consisting of red ginseng extract, spectral extract and thyme extract.
본 발명에 따르면, 상기 항균용 조성물을 이용하여 우리나라의 담수 및 해수 양식에 막대한 경제적 손실을 입히고 있는 세균성 질병 원인 중 하나인 스트렙토균의 어류에 대한 감염을 예방 및 치료 할 수 있다. 또한 한약재로 널리 사용되는 고삼, 관중 추출물과 허브 식물인 타임정유 추출물을 이용하여 궁극적으로는 장기간에 걸친 사용으로 내성균의 출현이 우려되는 항생제를 대체할 수 있으며, 기존 항생제와 동등 또는 그 이상의 효과를 가지면서 환경 친화적이고, 부가가치가 높은 천연항균제를 제공할 수 있다.According to the present invention, by using the antimicrobial composition, it is possible to prevent and treat infections of fish of Streptococcus, which is one of the causes of bacterial diseases causing enormous economic losses to freshwater and seawater cultures in Korea. In addition, by using ginseng, spectral extract and herb thyme extract, which are widely used as herbal medicines, it is possible to replace antibiotics that are concerned about the emergence of resistant bacteria through long-term use. It is possible to provide natural antibacterial agents which are environmentally friendly and have high added value.
항생제, 항균제, 연쇄구균, 고삼(Sophora flavescens), 관중(Dryopteris crassirhizoma), 타임(Thymus vulgaris) Antibiotics, Antibacterials, Streptococcus, Sophora flavescens, Crowd (Dryopteris crassirhizoma), Thymus vulgaris
Description
본 발명은 어류 세균성 질병유발 연쇄구균에 대해 항균능을 가지는 천연항균 조성물에 관한 것으로, 더욱 구체적으로 고삼 추출물, 관중 추출물 및 타임 추출물로 이루어진 군으로부터 선택된 1종 이상의 식물 추출물을 포함하는 항균용 조성물에 관한 것이다.The present invention relates to a natural antimicrobial composition having an antimicrobial activity against fish bacterial disease-induced streptococci, and more particularly to an antimicrobial composition comprising at least one plant extract selected from the group consisting of Gosam extract, spectral extract and thyme extract. It is about.
연쇄구균증의 원인체인 스트렙토코커스(Streptococcus sp.)는 우리나라를 포함한 미국, 이스라엘, 오스트레일리아, 일본 등지의 담수 및 해수 양식에 막대한 경제적 손실을 일으킨다. 스트렙토코커스는 박테리아의 한 속으로서 본 속의 많은 종들은 사람을 포함하는 많은 동물들에서 질병을 일으킨다. 본 종은 그람염색을 하였을 때 자주색이 나타나는 즉 그람 양성이다. 본 종이 그람양성임에 비하여 대부분 어류에 질병을 일으키는 박테리아들은 그람염색을 하였을 때 핑크색으로 되는 그람 음성균이다. 스트렙토코커스에 의한 어류의 질병은 그리 흔하지 않으나 일단 발병이 되면 많은 손실이 수반된다. 수생 스트레토코코스균은 그리 많지는 않으나 허약한 사람에게도 질병을 일으킬 수도 있다. 스트렙토코커스 이외에도 Lactococcus , Enterococcus 및 Vagococcus와 같은 종들도 스트렙토코커스와 유사한 질병을 일으킨다. 어류에서 포도상 구균병은 1957년 일본의 양식 송어에서 처음으로 규명되었다. 이후 연어, 숭어, golden shiner, pinfish, 뱀장어, 해산송어, 틸라피아, 철갑상어 및 농어 등이 본 질병에 잘 감염됨이 규명되었다. 또한 많은 종류의 관상어들도 잘 감염됨이 알려졌다. 현재 어류에 질병을 일으키는 종들을 예로 들면 이스라엘에서 규명된 Streptococcus difficilis, 비단잉어의 신장에서 발견된 S. milleri, 북부 스페인의 터봇(turbot)에서 발견된 S. parauberis, 어류와 포유류 모두에서 발견된 S. iniae 등을 들 수 있다. 또한 그람 양성 박테리아로서 포도상 구균과 매우 흡사하며 어류에 질병을 일으키는 종들로서는 일본의 뱀장어와 방어에서 발견된 Lactococcus garvieae와 무지게송에서 발견된 L. piscium 및 Vagococcus salmoninarum 등을 들 수 있다. Streptococcus sp. , The causative agent of streptococcosis , causes huge economic losses in freshwater and seawater farming in the United States, Israel, Australia and Japan, including Korea. Streptococcus is a genus of bacteria and many species in this genus cause disease in many animals, including humans. This species is Gram-positive, ie purple when Gram-dyed. Most of the bacteria that cause disease in fish are Gram-negative bacteria, which are pink when Gram-dyed. Fish disease caused by Streptococcus is not very common, but it does involve a lot of losses once developed. Aquatic Streptococcus bacteria are rare, but they can also cause disease in fragile people. In addition to Streptococcus , species such as Lactococcus , Enterococcus and Vagococcus also cause Streptococcus-like diseases. Staphylococcal disease in fish was first identified in 1957 in farmed trout in Japan. Salmon, mullet, golden shiner, pinfish, eel, marine trout, tilapia, sturgeon and sea bass have been found to be well-infected with the disease. Many species of ornamental fish are also known to be infected. Examples of species currently causing disease in fish include Streptococcus , which has been identified in Israel. difficilis , S. milleri found in the kidneys of Koi, S. parauberis found in the turbot of northern Spain, and S. iniae found in both fish and mammals. It is also a Gram-positive bacterium, very similar to Staphylococcus aureus, and Lactococcus found in Japanese eel and defenses as a species that causes disease in fish. found in garvieae and ignorant utterance L. piscium and Vagococcus salmoninarum and the like.
일반적으로, 연쇄구균증에 감염된 어류는 채색이 검어지고 안구 백탁 및 돌출의 증상을 보이고, 눈 가장자리 및 지느러미가 붉어진다. 감염 어류를 해부하면 간장의 충혈, 비대, 및 축소, 장관의 염증 및 출혈, 뇌출혈 그리고 아가미 뚜껑 내부에 농창이 형성된다. 또한, 감염된 어류는 감염초기에 식욕 감퇴로 인해 사료 섭이량이 급격히 감소하므로 약제 감수성 시험에서는 여러 약제가 효과적인 것으로 나타나지만 실제로 양식장에서 사용할 경우 효과적이지 못한 경우가 많다. 따라서 기존의 약물에 의한 치료위주의 방역 대책에서 양식 어류의 연쇄구균에 의한 피해예방을 위해 보다 근본적이면서 새로운 개념이 어류질병 예방 제제의 현장도입이 강하게 요구되고 있다. In general, fish infected with streptococcal show blackening, symptoms of ocular turbidity and protrusion, and redness of the edges and fins of the eyes. Dissecting infected fish results in hyperemia, hypertrophy and shrinkage of the liver, inflammation and bleeding in the intestine, cerebral hemorrhage, and thickening inside the gill cap. In addition, infected fish rapidly reduce feed intake due to loss of appetite in the early stages of infection, so many drugs appear to be effective in drug susceptibility testing, but they are often ineffective when used in aquaculture farms. Therefore, in order to prevent damage caused by Streptococcus of cultured fish in the treatment-oriented prevention measures by existing drugs, the introduction of a fish disease prevention agent is strongly required.
우리나라에서는 1980년대 이후 어류양식이 성행하면서 양식어의 질병예방 및 치료를 위하여 각종 항생제가 사용되어 왔으며, 장기간에 걸친 항생제 사용으로 인하여 해양세균에서 항생제 내성균 발생이 우려되고 있다. 세균의 항생제 내성을 결정하는 인자들은 플라스미드 전이에 의해 쉽게 다른 균체에 전달되는데 이러한 인자가 사람의 질병을 유발하는 세균에 전이될 수 있으며, 이 때 양식어류는 이러한 매개체 역할을 할 수도 있다고 보고 된 바 있다. In Korea, since the 1980s, fish farming has been active, various antibiotics have been used for disease prevention and treatment of farmed fish, and antibiotic-resistant bacteria in marine bacteria are feared due to the long-term use of antibiotics. Factors that determine antibiotic resistance in bacteria are easily transferred to other cells by plasmid transfer, which can be transferred to bacteria that cause human disease, and it has been reported that aquaculture fish can also act as such mediators. have.
특히, 연쇄구균증에 유효한 약제로는 플로르페니콜(Florfenicol), 암피실린(Ampicillin), 독시사이클린(Doxycyclin), 스피라마이신(Spiramysin) 등이 있다. 모두 수산용으로 증상에 따라 투여하면 치유되는 경우도 있지만, 거의 대부분 항생제 내성을 가지거나 뚜렷한 효과를 나타내지 않을 경우가 많다. Particularly effective drugs for streptococcosis include florfenicol, ampicillin, doxycyclin, spiramycin and the like. All of them can be cured if they are administered depending on the symptoms. However, almost all of them have antibiotic resistance or no clear effect.
이러한 항생제에 대한 내성 문제를 해결하기 위하여 이를 대체할 수 있는 천연 소재를 활용하고자 많은 시도를 하고 있다. 예로부터 한약재 추출물이나 식물정유는 식용 또는 약용으로 이용되어져 왔으며 최근에는 이러한 자원을 이용하여 항균, 항진균 및 항암효과를 갖는 물질에 관한 연구가 활발히 진행되고 있다. 식품에 존재하여 사람에게 해를 입히는 세균들에 대한 항균효과에 대해서는 많은 보고가 되고 있지만, 양식어류에 질병을 일으키는 세균에 대한 천연물의 항균효과에 대한 연구는 시작단계에 있다. 현재 양식장에서 발병하는 연쇄구균에 대한 구체적인 효능, 즉 항균 효과에 대해서 천연식물 추출물을 이용하여 어류 질병 세균에 대한 효능을 구명하고 실제적으로 연쇄구균에 사용되는 항생제를 대체할 항균 조성물을 개발하는 것은 시급한 실정이다.In order to solve the problem of resistance to antibiotics, many attempts have been made to utilize natural materials that can replace them. Since ancient times, herbal extracts and plant essential oils have been used for edible or medicinal purposes. Recently, studies on substances having antimicrobial, antifungal and anticancer effects have been actively conducted using these resources. There are many reports on the antimicrobial effects of bacteria present in foods that harm humans, but research on the antimicrobial effects of natural products on bacteria that cause diseases in farmed fish is in the beginning stages. It is urgent to develop an antimicrobial composition to find out the efficacy on fish disease bacteria using natural plant extracts for the specific efficacy of the streptococci that occur in the farm, and to replace the antibiotics actually used for streptococci. It is true.
고삼(Sophora flavescens)은 콩과에 속하는 다년생 초본식물로 한방에서는 뿌리를 약재로 이용한다. 우리나라 전 지역에 자생하며, 살충제, 진통제, 구충제로 쓰인다. 관중(Dryopteris crassirhizoma)은 여러해살이 풀로서 뿌리를 약제로 이용한다. 구충작용, 자궁에 대한 작용, 암치질로 인한 변혈, 적리, 대하증에 대한 치료효과를 나타내고, 독을 함유하여 임산부, 소아, 소화기관 궤양 환자에게는 좋지 않으나, 일반적으로 위장에서 흡수되지 않아 오랫동안 한약재로 이용되어 왔다. 타임(Thymus vulgaris)은 남부유럽의 지중해 연안이 원산지로 꿀풀과에 속하는 다년생의 낙엽 소관목으로 아열대부터 온대에 걸쳐 자생하고 있으며, 그 효과는 방부성, 항산화성, 살충성, 및 식품 보존의 효과가 있다. 최근에는 허브 및 조경소재로 급격히 수요가 증가하고 있으나 주로 향미적인 특성과 항산화 물질 탐색에만 집중 되어 있다.Ginseng ( Sophora flavescens ) is a perennial herbaceous plant belonging to the legumes. It grows wild all over Korea and is used as insecticide, painkiller, and insect repellent. Spectators ( Dryopteris crassirhizoma ) is a perennial grass that uses the root as a medicine. Insect repellent, action on the uterus, hemorrhage due to hemorrhoids, hemorrhoids, schizophrenia, it is not good for pregnant women, children, ulcer patients with gastrointestinal ulcers. Has been. Thymus vulgaris ) is a perennial deciduous shrub belonging to Lamiaceae, native to the Mediterranean coast of southern Europe, and grows from subtropical to temperate. Its effects are antiseptic, antioxidant, insecticidal, and food preservation. Recently, the demand for herbs and landscaping materials has been increasing rapidly, but mainly focused on the flavor characteristics and antioxidants.
이에, 본 발명자들은 상기 종래기술들의 문제점들을 극복하기 위하여 예의 연구노력한 결과, 고삼 추출물, 관중 추출물, 타임 추출물 또는 이들의 혼합물을 처리하는 경우, 양식어류에 질병을 일으키는 연쇄구균에 대해 효과적인 억제를 할 수 있음을 확인하고, 본 발명을 완성하게 되었다.Accordingly, the present inventors have made intensive research to overcome the problems of the prior art, when processing ginseng extract, spectral extract, thyme extract, or mixtures thereof, effective suppression against streptococci causing disease in aquaculture fish. After confirming that it can, the present invention was completed.
따라서, 본 발명의 주된 목적은 항생제 내성균 발생과 내성 전이의 우려가 없고, 기존 항생제의 항균 효과와 비교하여 동등 또는 그 이상의 효과를 갖는 어류 세균성 질병유발 연쇄구균에 대해 항균능을 가지는 천연 항균 조성물을 제공하는 데 있다.Accordingly, the main object of the present invention is to provide a natural antimicrobial composition having an antimicrobial activity against fish bacterial disease-causing streptococci without the risk of antibiotic resistant bacteria and resistance transfer, and having the same or more effects compared to the antimicrobial effects of conventional antibiotics. To provide.
본 발명의 다른 목적은 상기 어류 세균성 질병유발 연쇄구균에 대해 항균능을 가지는 천연 항균 조성물을 이용하여 우리나라의 담수 및 해수 양식에 막대한 경제적 손실을 입히고 있는 세균성 질병 원인 중 하나인 스트렙토균의 어류에 대한 감염을 예방 및 치료 하는데 있다.Another object of the present invention by using a natural antimicrobial composition having an antimicrobial activity against the bacterial bacterial disease-induced streptococci against the fish of Streptococcus, which is one of the causes of bacterial diseases causing enormous economic losses to freshwater and seawater culture in Korea To prevent and treat infections.
본 발명의 한 양태에 따르면, 본 발명은 고삼 추출물, 관중 추출물 및 타임 추출물로 이루어진 군으로부터 선택된 1종 이상의 식물 추출물을 포함하는 항균용 조성물을 제공한다. 본 발명의 상기 고삼(Sophora flavescens)은 콩과에 속하는 다년생 초본식물로 우리나라 전 지역에 자생한다. 고삼 추출물의 주요 성분은 마트린, 옥시마트린, 소포라놀, 아나기린, 메틸시티진, 바브티플린, 소포카르핀, 및 알로마트린이다. 본 발명의 관중(Dryopteris crassirhizoma)은 여러해살이 양치식물로 그늘에서 자라며 우리 나라 산지 수림 밑에서 흔히 불 수 있다. 관중 추출물의 주요 성분은 바이카린, 바이카레인, 및 워고닌이다. 본 발명의 타임(Thymus vulgaris)은 남부유럽의 지중해 연안이 원산지이고, 꿀풀과에 속하는 다년생의 낙 엽 소관목이고, 아열대부터 온대에 걸쳐 자생하고 있다. 타임 추출물의 주요 성분은 티몰, 카바크롤, 리날로올, 및 플라보노이드이다. 일반적으로 추출물의 항균효과는 구성성분이 크게 페닐프로판, 테르핀(Terpine)으로 구성되는데 테르핀의 옥사이드, 에스테르, 알코올, 페놀, 알데히드, 케톤, 모노테르핀, 세스키트테르핀 등의 활성과 함량에 의해서 결정된다. 이러한 구성성분들은 단순한 분자구조가 아니라 매우 복잡한 구조를 갖고 있으며, 항바이러스 작용과 항균, 항 곰팡이 작용을 하는 것으로 밝혀지고 있다. 이들 성분들은 강한 방부 효과 및 항균특징을 가지고 있으며, 그 외 약 100여 가지 성분이 서로 상호작용을 하여 강한 치료력과 항균 특성을 갖는다. 따라서 본 발명의 상기 식물 추출물을 혼합하는 경우 추출물의 주요 성분들이 일으키는 시너지 효과에 의해 우수한 항균 작용을 나타낸다.According to one aspect of the present invention, the present invention provides an antimicrobial composition comprising one or more plant extracts selected from the group consisting of red ginseng extract, spectral extract and thyme extract. The ginseng of the present invention (Sophora flavescens) Is a perennial herbaceous plant belonging to the legume family and grows all over Korea. The main components of the ginseng extract are matrin, oxymatrine, sophoranol, anagiline, methylcytizin, barbtiphrine, sofocarpine, and allomatrine. The audience of the present invention (Dryopteris crassirhizoma) Is a perennial fern that grows in the shade and can be blown under the forests of our country. The main components of the spectral extracts are bicarin, bicarin, and wogonin. Time of the invention (Thymus vulgaris) Is native to the Mediterranean coast of southern Europe, is a perennial deciduous shrub belonging to the Lamiaceae family, and grows from subtropical to temperate. The main components of the thyme extract are thymol, carbacroll, linalool, and flavonoids. In general, the antimicrobial effect of the extract consists of phenylpropane and terpine, which are composed mainly of oxides, esters, alcohols, phenols, aldehydes, ketones, monoterpines and sesquiterpines. Determined by These components are not just molecular structure but have a very complex structure and have been shown to have antiviral, antibacterial and antifungal effects. These ingredients have a strong antiseptic effect and antibacterial properties, and about 100 other components interact with each other to have strong therapeutic power and antibacterial properties. Therefore, when mixing the plant extract of the present invention exhibits excellent antibacterial action by the synergistic effect caused by the main components of the extract.
본 발명의 항균용 조성물에서, 상기 항균은 본 발명의 천연 추출물을 처리하여 사멸되는 어떠한 균에 대한 항균도 될 수 있으나, 바람직하게는 스트렙토코커스(Streptococcus) 속에 속하는 균에 대한 항균인 것이 좋고, 더욱 바람직하게는 스트렙토코커스 이니아에(Streptococcus iniae) 종에 대한 항균인 것이 좋다. In the antimicrobial composition of the present invention, the antimicrobial may be an antimicrobial against any bacteria that are killed by treating the natural extract of the present invention, but preferably, antimicrobial against a bacterium belonging to the Streptococcus genus. Preferably Streptococcus iniae ) is good antimicrobial against species.
본 발명의 항균용 조성물에서, 상기 조성물은 세균 감염의 예방 및 치료 목적으로 동물체에 투여할 수 있으나, 바람직하게는 어류에 투여하는 것이 좋다. 상기 투여 가능한 어류의 예로서 넙치, 조피볼락, 방어, 송어, 뱀장어, 잉어, 메기 등이 있다.In the antimicrobial composition of the present invention, the composition may be administered to an animal body for the purpose of preventing and treating a bacterial infection, but is preferably administered to fish. Examples of such administrable fish include flounder, sea bass, defense, trout, eel, carp, catfish and the like.
본 발명의 항균용 조성물에서, 상기 식물 추출물은 상기 식물을 물, 에탄올, 이소프로필 알콜, 메탄올, 프로판올, 부탄올, 글리세린, 부틸렌글리콜 및 그 혼합 물로 이루어진 군으로부터 선택된 1종 이상의 용매를 사용하여 추출할 수 있으며, 바람직하게는 물, 탄소수 1 내지 5의 저급 알콜, 또는 그 혼합물을 용매로 사용하여 추출할 수 있다. 본 발명의 실시예에서는 물과 에탄올의 혼합용매를 사용하여 고삼과 관중을 추출하였다. In the antimicrobial composition of the present invention, the plant extract is extracted with at least one solvent selected from the group consisting of water, ethanol, isopropyl alcohol, methanol, propanol, butanol, glycerin, butylene glycol and mixtures thereof. Preferably, water, lower alcohols having 1 to 5 carbon atoms, or a mixture thereof can be used as a solvent for extraction. In the embodiment of the present invention using a mixed solvent of water and ethanol extracted the ginseng and the crowd.
본 발명의 항균용 조성물에서, 상기 선택된 식물 추출물은 타임 및 고삼의 추출물인 것이 바람직하며, 타임 추출물과 고삼 추출물의 중량비가 1 : 0.2 내지 1 : 5 인 것이 좋다. 본 발명의 실시예에서는 타임 추출물과 고삼 추출물을 상기 비율로 혼합하여 처리하여 혼합물의 항균능력을 검정하였다. 그 결과 타임 추출물과 고삼 추출물을 각각 1(15㎕):1(15㎕), 1(7.5㎕):3(22.5㎕), 1(5㎕):5(25㎕), 3(22.5㎕):1(7.5㎕), 및 5(25㎕):1(5㎕)의 비율로 혼합하여 처리한 경우 고삼 추출물을 단독 처리한 경우(고삼 30㎕) 보다 173.3%(2.6÷ 1.5× 100=173.3) 증가된 효과를 관찰하였다.In the antimicrobial composition of the present invention, the selected plant extract is preferably an extract of thyme and ginseng, and the weight ratio of the thyme extract and the ginseng extract is preferably 1: 0.2 to 1: 5. In the embodiment of the present invention, the antibacterial ability of the mixture was assayed by treating the thyme extract and the ginseng extract at the above ratios. As a result, 1 (15μl): 1 (15μl), 1 (7.5μl): 3 (22.5μl), 1 (5μl): 5 (25μl), 3 (22.5μl) 17: 1% (2.6 ÷ 1.5 × 100 = 173.3) when mixed with 1: 1 (7.5µl) and 5 (25µl): 1 (5µl) treatments ) Increased effect was observed.
본 발명의 항균용 조성물에서, 상기 선택된 식물 추출물은 타임 및 관중의 추출물인 것이 바람직하며, 타임 추출물과 관중 추출물의 중량비가 1 : 0.2 내지 1 : 5 인 것이 좋다. 본 발명의 실시예에서는 타임 추출물과 관중 추출물을 상기 비율로 혼합하여 처리하여 혼합물의 항균능력을 검정하였다. 그 결과 타임 추출물과 관중 추출물을 각각 1(15㎕):1(15㎕), 3(22.5㎕):1(7.5㎕), 및 5(25㎕):1(5㎕)의 비율로 혼합하여 처리한 경우 관중 추출물(30㎕)을 단독 처리한 경우 보다 171.4%(2.4÷ 1.4× 100=171.4) 증가된 효과를 관찰하였고, 1(7.5㎕):3(22.5㎕), 및 1(5㎕):5(25㎕)의 비율로 혼합하여 처리한 경우 관중 추출물을 단독 처리한 경 우(관중 30㎕) 보다 각각 182.1%(2.55÷ 1.4× 100=182.1), 178.5%(2.5÷ 1.4× 100=178.5) 증가된 효과를 관찰하였다. 한약재 추출물인 고삼과 관중을 단독으로 처리 시 저지대 크기가 작은데 비하여 타임과 소량 혼합했을 경우는 저지대 크기가 현저하게 증가하였다. 이러한 결과는 고삼과 관중이 저렴하여 타임을 소량 혼합하는 방식으로 사용할 수 있다.In the antimicrobial composition of the present invention, the selected plant extract is preferably an extract of thyme and spectators, and the weight ratio of thyme extract and spectral extract is 1: 0.2 to 1: 5. In the embodiment of the present invention, the antibacterial ability of the mixture was assayed by treating the thyme extract and the spectral extract in the above ratios. As a result, the thyme extract and the spectral extract were mixed at a ratio of 1 (15 μl): 1 (15 μl), 3 (22.5 μl): 1 (7.5 μl), and 5 (25 μl): 1 (5 μl), respectively. When treated, the effect was increased by 171.4% (2.4 ÷ 1.4 × 100 = 171.4) compared with the spectral extract (30 μl) alone, 1 (7.5 μl): 3 (22.5 μl), and 1 (5 μl). ): 5 (25 μl), when mixed and treated with extracts of spectral extract alone (30 μl in spectral), 182.1% (2.55 ÷ 1.4 × 100 = 182.1) and 178.5% (2.5 ÷ 1.4 × 100), respectively. = 178.5) increased effect was observed. Low ginseng and spectral extracts, which were the herb extracts, were significantly lower than those of thyme when mixed with thyme. These results can be used in a way that small amounts of thyme ginseng and the crowd is cheap.
이하, 본 발명의 어류 세균성 질병유발 연쇄구균에 대해 항균능을 가지는 천연 항균 조성물의 제조 및 항균력에 대한 평가를 단계별로 보다 구체적으로 설명한다. 본 발명자들은 정유 추출물 9종과 한약재 6종에 대하여 스트렙토코커스 균에 대한 항균 능력을 여지확산법(Paper disc diffusion method)으로 검정하였다. 그 결과 쇄구균에 대한 천연항균조성물은 고삼추출물, 관중추출물, 타임정유가 스트렙토코커스 균에 대한 항균 능력을 보임을 발견하였다. 또한 본 발명자들은 항균제로 통상 사용되는 암피실린과 상기 식물 추출물들의 항균능력을 비교하였고, 우수한 항균 능력을 보이는 타임 정유와 경제적인 비용 부담이 적은 고삼 추출물 및 관중추출물을 각각 혼합하여 혼합물의 항균효과를 검증하였다. Hereinafter, the production of natural antimicrobial compositions having antimicrobial activity against the bacterial bacterial disease-induced streptococci of the present invention will be described in more detail step by step for evaluation of antimicrobial activity. The present inventors assayed the antimicrobial activity against Streptococcus bacteria against 9 essential oil extracts and 6 medicinal herbs by the paper disc diffusion method. As a result, natural antibacterial composition against streptococci was found to have antibacterial ability against Streptococcus bacteria from Gosam extract, spectral extract and thyme essential oil. In addition, the present inventors compared the antibacterial ability of the ampicillin commonly used as an antimicrobial agent and the plant extracts, and verified the antimicrobial effect of the mixture by mixing the time essential oil showing excellent antibacterial ability, and the gossip extract and the spectral extract, which are less economically expensive. It was.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for illustrating the present invention, and thus the scope of the present invention is not construed as being limited by these embodiments.
실시예Example 1. 항균 효과를 갖는 천연 식물 소재 및 식물 정유의 선발 1. Selection of natural plant material and plant essential oils with antimicrobial effect
연쇄구균에 대한 정유추출물 10종과 한약재추출물 6종을 agar well diffusion method를 사용하여 처리하였을 때의 연쇄구균 성장억제 및 제거 효과에 대하여 나타내었다. agar well diffusion method는 균에 대한 항균활성을 비교하거나 검정하는데 있어 사용되는 방법이다. Pancreatic digest of casein 17g/L, Enzymatic digest of soybean meal 3g/L, Dextrose 2.5g/L, Sodium chloride 20g/L, Dipotassium phosphate 2.5g/L, Agar 15g/L를 이용한 ST 배지에 OD 600nm에서 1.0으로 맞춘 연쇄구균 배양액을 플레이트별로 100㎕ 되도록 하여 agar의 함유량이 7.5g/L로 한 ST 배지에 접종하여 미리 준비해둔 ST 플레이트에 붓고 마를 때 까지 기다린 후 천연물질 추출물을 각 홀에 30㎕ 넣은 후 27℃에서 24시간 반응을 시켜 항균능을 확인하였다. 상기 천연물질 추출물은 정유추출물 10종과 한약재추출물 6종을 사용하였는데, 각각 레몬글라스, 사이프레스프렌치, 펜넬, 페츌리, 라벤더프렌치, 버가못, 티트리, 타임, 라벤더, 제라늄, 관중, 황련, 황백, 고삼, 정향, 및 황금을 선발하여 시험하였다. 그 결과 고삼, 관중, 및 타임 추출물을 첨가한 배지에서 생육저해환을 관찰하였다. 천연추출물 고삼, 관중 및 타임의 주요 성분은 표 1에 나타내었다.The effects of Streptococcus growth inhibition and elimination on the treatment of 10 essential oil extracts and 6 medicinal herb extracts against the Streptococcus by the agar well diffusion method are shown. The agar well diffusion method is a method used to compare or test antimicrobial activity against bacteria. Pancreatic digest of casein 17g / L, Enzymatic digest of soybean meal 3g / L, Dextrose 2.5g / L, Sodium chloride 20g / L, Dipotassium phosphate 2.5g / L, Agar 15g / L from OD 600nm to 1.0
[표 1]. 천연추출물인 고삼, 관중 및 타임 추출물의 주요 성분TABLE 1 Major Components of Natural Extracts of Red Ginseng, Species and Thyme Extracts
(Sophora flavesceus)Gosam
( Sophora flavesceus )
(Dryopteris crassirhizoma)crowd
( Dryopteris crassirhizoma )
(Thymus vulgaris)time
( Thymus vulgaris )
실시예Example 2. 천연물 추출액의 제조 2. Preparation of natural product extract
본 발명에 사용된 천연물질인 고삼과 관중의 추출물은 햇볕에 건조한 고삼과 관중의 뿌리를 각각 10배 중량의 50% 에탄올에 7시간 동안 침지하여 추출하였다. 타임 정유는 진아향료(주)에서 구입하였는데 이는 수증기 증류법(steam distillation)으로 제조된 것이다.Natural extracts of ginseng and spectators used in the present invention were extracted by immersing the roots of sun-dried ginseng and spectators in 50% ethanol each of 10-fold weight for 7 hours. Thyme essential oil was purchased from Jina Flavor Co., Ltd., which was manufactured by steam distillation.
실시예Example 3. 병원성 3. Pathogenicity 연쇄구균의Streptococcal 동정 및 Sympathy and 계대배양Subculture
고삼 및 관중 추출물과 타임정유의 항균 효과 및 효능을 측정하기 위하여 연쇄구균 감염이 의심되는 넙치(Paralichthys olivaceus)에서 연쇄구균을 분리하였다. 분리한 연쇄구균은 순수분리 과정을 통하여 Brain heart digest 17.5g/L, Proteose peptone 10.0g/L, Dextrose 2.0g/L, Sodium chloride 5.0g/L, Disodium phosphate 2.50g/L, Agar 15.0g/L를 이용한 BHIA배지 (agar)를 이용하여 균주를 계대배양 하면서 각각의 실험에 사용하였다. 순수 분리된 연쇄구균(Streptococcus sp.)은 genomic DNA를 분리하여 16S rRNA sequencing 분석을 통하여 연쇄구균(Streptococcus sp.)(Gene Bank Data homology search result : 99%)의 동정과 분석 후 사용하였다. To evaluate the antimicrobial effect and efficacy of Gosam and Species extract and thyme essential oil, flounder ( Paralichthys) Streptococci were isolated from olivaceus ). The isolated streptococci were brain heart digest 17.5g / L, Proteose peptone 10.0g / L, Dextrose 2.0g / L, Sodium chloride 5.0g / L, Disodium phosphate 2.50g / L, Agar 15.0g / L BHIA medium (agar) using the strain was used for each experiment while subcultured. Purely Isolated Streptococcus sp. ) Was used to identify and analyze Streptococcus sp. (Gene Bank Data homology search result: 99%) through 16S rRNA sequencing analysis.
실시예Example 4. 4. AgarAgar wellwell diffusiondiffusion methodmethod 를 통한 Through 고삼Gosam , 관중, 타임 추출물의 농도별 항균 효과 검증Of antimicrobial effect by concentration of extracts, spectators and thyme extracts
Pancreatic digest of casein 17g/L, Enzymatic digest of soybean meal 3g/L, Dextrose 2.5g/L, Sodium chloride 20g/L, Dipotassium phosphate 2.5g/L, Agar 15g/L를 이용한 ST 배지에 OD 600nm에서 1.0으로 맞춘 연쇄구균 배양액을 플레이트별로 100㎕ 되도록 하여 agar의 함유량이 7.5g/L로 한 ST 배지에 접종하여 미리 준비해둔 ST 플레이트에 붓고 마를 때 까지 기다린 후 Ampicillin (control), 천연물질 추출물을 원액 ~ 1.0% 까지 희석하여 각 홀에 30㎕ 넣은 후 27℃에서 24시간 반응을 시켜 항균능을 확인하였다. 한약재 중 고삼과 관중추출물, 그리고 타임 정유추출물을 선택하여 각각의 추출물을 희석하여 처리하였을 때에도 항균능의 상승을 나타내는지에 대하여 확인을 하였다. 희석처리 실험 역시 agar well method diffusion method를 사용하여 원액 ~ 1% 까지 희석처리 하여 연쇄구균의 성작억제 및 제거 효과에 대하여 나타내었고, 대조군으로 연쇄구균증의 항생제인 암피실린(Ampicillin)을 사용하였다. 도 1 및 표 2에 연쇄구균에 대한 암피실린과 고삼, 관중, 타임정유 추출물의 희석농도별로 agar well diffusion method를 사용하여 처리하였을 때의 연쇄구균 성장억제 및 제거 효과에 대하여 나타내었다. Pancreatic digest of casein 17g / L, Enzymatic digest of soybean meal 3g / L, Dextrose 2.5g / L, Sodium chloride 20g / L, Dipotassium phosphate 2.5g / L, Agar 15g / L from OD 600nm to 1.0
[표 2]. 암피실린과 고삼, 관중, 타임정유 추출물의 희석별 항균 효과TABLE 2 Antibacterial Effects of Ampicillin, Red Ginseng, Species and Thyme Essential Oil Extracts by Dilution
실시예Example 5. 5. 고삼Gosam , 관중, 타임 추출물의 혼합처리 시 , Mixed with spectral extracts 연쇄구균Streptococcus 억제효과 실험방법 Inhibitory effect test method
상기 실시예 3에서 100 배 희석 처리까지 가장 높은 억제능을 보였던 타임정유 추출물을 중심으로 고삼과 관중 추출물을 첨가 혼합하였을 때 단독으로 처리시보다 효능이 상승하는 지에 대한 상승효과를 확인하였다. 혼합 추출물의 항균능 역시 실시예 3의 agar well method diffusion method를 사용하였다. 타임 : 고삼 또는 타임 : 관중을 각각 1:1 ~ 1:5 까지 혼합처리 하여 각 홀에 30㎕ 넣은 후 27℃에서 24시간 반응을 시켜 연쇄구균 성장억제 및 제거 효과를 타임, 고삼, 또는 관중의 단독을 30㎕ 넣은 것과 비교 관찰하였다(도 2 및 표 3). In Example 3, when synergistically added and mixed with red ginseng and spectral extracts based on thyme essential oil extract showed the highest inhibitory ability up to 100-fold dilution treatment, it confirmed the synergistic effect of increasing the efficacy than the treatment alone. The antibacterial activity of the mixed extract was also used in the agar well method diffusion method of Example 3. Time: Gosam or Time: Mix the crowd 1: 1 to 1: 5, put 30µL into each hole, and react for 24 hours at 27 ℃ to prevent streptococcal growth inhibition and removal. It was compared with 30 μl alone (Fig. 2 and Table 3).
[표 3]. 한약재 추출물과 타임정유 추출물의 혼합 처리 시 연쇄구균 억제효과TABLE 3 Inhibitory Effects of Streptococcus on the Treatment of Herbal Extracts and Time Essential Oil Extracts
이상 설명한 바와 같이, 본 발명에 따르면, 고삼 추출물, 관중 추출물, 타임정유, 또는 그 혼합물을 포함하는 항균용 조성물을 이용하여 우리나라의 담수 및 해수 양식에 막대한 경제적 손실을 입히고 있는 세균성 질병 원인 중 하나인 스트렙토균의 어류에 대한 감염을 예방 및 치료 할 수 있다. As described above, according to the present invention, by using an antimicrobial composition comprising a ginseng extract, spectral extract, thyme essential oil, or a mixture thereof, one of the causes of bacterial diseases causing enormous economic loss to freshwater and seawater culture in Korea. It can prevent and treat the infection of Streptococcus fish.
또한 한약재로 널리 사용되는 고삼, 관중 추출물과 허브 식물인 타임정유 추출물을 이용하여 궁극적으로는 장기간에 걸친 사용으로 내성균의 출현이 우려되는 항생제를 대체할 수 있으며, 기존 항생제와 동등 또는 그 이상의 효과를 가지면서 환경 친화적이고, 부가가치가 높은 천연항균제를 제공할 수 있다. 본 발명의 타임정유, 고삼 추출물, 관중 추출물, 또는 그 혼합물은 어류 양식 산업에서 항생제들을 대체할 수 있으며, 고삼이나 관중은 저렴한 가격으로 쉽게 구할 수 있기 때문에 경제적 부가가치도 높다. 또한, 본 발명은 친환경적 천연추출물을 항생제로 사용하 여 기존 항생제의 어체 내 축적 및 내성균 발현 등의 문제점을 해결하고, 양식어류에 대한 불신을 없앰으로써 소비 촉진을 통한 양식 산업의 생산성 증대에 기여할 것이다.In addition, by using ginseng, spectral extract and herb thyme extract, which are widely used as herbal medicines, it is possible to replace antibiotics that are concerned about the emergence of resistant bacteria through long-term use. It is possible to provide natural antibacterial agents which are environmentally friendly and have high added value. Time essential oil, ginseng extract, spectral extract, or mixtures thereof of the present invention can replace antibiotics in the fish farming industry, and because ginseng or spectators are readily available at low prices, they also have high economic added value. In addition, the present invention will use environmentally friendly natural extracts as antibiotics to solve problems such as accumulation of existing antibiotics in fish bodies and expression of resistant bacteria, and will contribute to increasing productivity of the aquaculture industry by promoting consumption by eliminating distrust in farmed fish. .
도 1은 고삼(GS), 관중(KJ), 및 타임정유(TM)와 각각의 희석액의 항균능을 agar well diffusion method로 평가한 사진이다. A-1 내지 A-3의 사진은 암피실린(10, 8, 6, 4, 2, 1, 0.8, 0.6, 0.4, 0.2, 0.1, 단위 ㎍)을 대조군으로 각각 처리한 경우 관찰된 사진이고, B-1 내지 B-3의 사진은 고삼추출물 및 그 희석액(100, 80, 60, 40, 20, 10, 5, 3, 및 1 %)을 처리한 경우 각각 관찰된 사진이고, C-1 내지 C-3의 사진은 관중추출물과 그 희석액(100, 80, 60, 40, 20, 10, 5, 3, 및 1 %)을 처리한 경우 관찰된 사진이고, D-1 내지 D-4는 타임정유 추출물과 그 희석액(100, 60, 40, 20, 3, 1, 및 0.5 %)을 각각 처리한 경우 관찰된 사진이다. 1 is a photograph evaluating the antibacterial activity of ginseng (GS), spectral (KJ), thyme oil (TM) and each dilution by the agar well diffusion method. Photos of A-1 to A-3 are photographs observed when Ampicillin (10, 8, 6, 4, 2, 1, 0.8, 0.6, 0.4, 0.2, 0.1, unit μg) was treated as a control group, respectively. B The photographs of -1 to B-3 are photographs observed when the high ginseng extract and its dilutions (100, 80, 60, 40, 20, 10, 5, 3, and 1%) were treated, respectively. The photo of -3 is the photograph observed when the spectral extract and its dilution (100, 80, 60, 40, 20, 10, 5, 3, and 1%) is treated, D-1 to D-4 is time refined The photographs were observed when the extract and its dilutions (100, 60, 40, 20, 3, 1, and 0.5%) were treated respectively.
도 2는 타임정유(TM)와 고삼(GS) 또는 관중(KJ) 추출물의 혼합물의 항균능을 agar well diffusion method로 평가한 사진이다. A-1 내지 A-3의 사진은 타임정유(TM)와 고삼(GS)을 각각 1:1, 1:3, 1:5, 3:1, 5:1의 비율로 혼합하여 처리할 때 관찰되는 사진이고, B-1 내지 B-3의 사진은 타임정유(TM)와 관중(KJ) 추출물을 각각 1:1, 1:3, 1:5, 3:1, 5:1의 비율로 혼합하여 처리할 때 관찰되는 사진이다.Figure 2 is a photograph evaluating the antibacterial activity of the mixture of essence essential oil (TM) and goose (GS) or spectral (KJ) extract by the agar well diffusion method. The photographs of A-1 to A-3 are observed when time oil (TM) and ginseng (GS) are mixed and treated in a ratio of 1: 1, 1: 3, 1: 5, 3: 1, and 5: 1, respectively. Photos of B-1 to B-3 are mixed with essential oil (TM) and spectral (KJ) extract in the ratio of 1: 1, 1: 3, 1: 5, 3: 1 and 5: 1, respectively. It is a photograph observed when processing.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070134699A KR101006556B1 (en) | 2007-12-20 | 2007-12-20 | Anti-bacterial compositions against Streptococcus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070134699A KR101006556B1 (en) | 2007-12-20 | 2007-12-20 | Anti-bacterial compositions against Streptococcus |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090066949A KR20090066949A (en) | 2009-06-24 |
KR101006556B1 true KR101006556B1 (en) | 2011-01-07 |
Family
ID=40994887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070134699A KR101006556B1 (en) | 2007-12-20 | 2007-12-20 | Anti-bacterial compositions against Streptococcus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101006556B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019017676A3 (en) * | 2017-07-18 | 2019-02-21 | 연세대학교 산학협력단 | Composition comprising ethyl vanillin as effective ingredient for exhibiting effect of muscle strengthening, muscle enhancement, muscle differentiation, muscle regeneration, or sarcopenia suppression |
WO2019146826A1 (en) * | 2018-01-29 | 2019-08-01 | 전진바이오팜 주식회사 | Composition for preventing or treating parasitic infections in fish, comprising sophora flavescens aiton extract or fraction thereof |
WO2019146827A1 (en) * | 2018-01-29 | 2019-08-01 | 전진바이오팜 주식회사 | Composition for preventing or treating parasitic infections in fish, comprising helianthus tuberosus extract and sophora flavescens aiton extract |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104824051B (en) * | 2015-05-21 | 2017-11-17 | 北京联合大学 | A kind of subprostrate sophora, rhizome of cyrtomium agricultural compound bactericide and preparation method thereof |
KR102269881B1 (en) * | 2018-03-14 | 2021-06-29 | 정연옥 | Composition with antimicrobial or antifungal activity comprising dryopteris crassirhizoma nakai extract, salvia miltiorrhiza bunge extract and scutellaria baicalensis extract and method for preaparing the same |
RU2684780C1 (en) * | 2018-05-23 | 2019-04-15 | федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Method for producing liquid thyme extract |
KR102130129B1 (en) | 2018-11-14 | 2020-07-03 | 국민대학교산학협력단 | Antibiotic composition containing extract of Acori Gramineri Rhizoma and extract of Phellodendron Cortex |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6475426A (en) * | 1987-09-17 | 1989-03-22 | Nisshin Flour Milling Co | Prophylactic and remedy for streptococcal infection in fishes |
JPH0632741A (en) * | 1992-07-15 | 1994-02-08 | Mitsubishi Petrochem Co Ltd | Agent for preventing and treating microbism of fishes and its use |
-
2007
- 2007-12-20 KR KR1020070134699A patent/KR101006556B1/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6475426A (en) * | 1987-09-17 | 1989-03-22 | Nisshin Flour Milling Co | Prophylactic and remedy for streptococcal infection in fishes |
JPH0632741A (en) * | 1992-07-15 | 1994-02-08 | Mitsubishi Petrochem Co Ltd | Agent for preventing and treating microbism of fishes and its use |
Non-Patent Citations (2)
Title |
---|
논문1: 한국약용작물학회지* |
논문2; 한국어병학회지 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019017676A3 (en) * | 2017-07-18 | 2019-02-21 | 연세대학교 산학협력단 | Composition comprising ethyl vanillin as effective ingredient for exhibiting effect of muscle strengthening, muscle enhancement, muscle differentiation, muscle regeneration, or sarcopenia suppression |
US11576875B2 (en) | 2017-07-18 | 2023-02-14 | Industry-Academic Cooperation Foundation, Yonsei University | Composition comprising ethyl vanillin as effective ingredient for exhibiting effect of muscle strengthening, muscle enhancement, muscle differentiation, muscle regeneration, or sarcopenia suppression |
WO2019146826A1 (en) * | 2018-01-29 | 2019-08-01 | 전진바이오팜 주식회사 | Composition for preventing or treating parasitic infections in fish, comprising sophora flavescens aiton extract or fraction thereof |
WO2019146827A1 (en) * | 2018-01-29 | 2019-08-01 | 전진바이오팜 주식회사 | Composition for preventing or treating parasitic infections in fish, comprising helianthus tuberosus extract and sophora flavescens aiton extract |
GB2583664A (en) * | 2018-01-29 | 2020-11-04 | Jeonjin Bio Co Ltd | Composition for preventing or treating parasitic infections in fish, comprising Sophora flavescens Aiton extract or fraction thereof |
GB2583664B (en) * | 2018-01-29 | 2022-09-14 | Jeonjin Bio Co Ltd | Composition for preventing or treating sea lice infections in fish, comprising an extract of Sophora Flavescens Aiton or a fraction thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20090066949A (en) | 2009-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101006556B1 (en) | Anti-bacterial compositions against Streptococcus | |
Turker et al. | Sensitivity of bacteria isolated from fish to some medicinal plants | |
Rattanachaikunsopon et al. | Prophylactic effect of Andrographis paniculata extracts against Streptococcus agalactiae infection in Nile tilapia (Oreochromis niloticus) | |
Adeniyi et al. | Effects of dietary tamarind (Tamarindus indica L.) leaves extract on growth performance, nutrient utilization, gut physiology, and susceptibility to Aeromonas hydrophila infection in Nile tilapia (Oreochromis niloticus L.) | |
KR101107034B1 (en) | Feed additives for cultivated fish consisting herbal mixture water extracts of sophorae flavescens aition, citrus unshiu markovich, lonicera japonica thunberg, benincasa hispida cogniaux, perilla frutescens var. acuta kudo and scutellaria baicalensis georgi as an active ingredient and feed for cultivated fish therewith | |
Mapanao et al. | The effect of banana blossom on growth performance, immune response, disease resistance, and anti-hypothermal stress of Macrobrachium rosenbergii | |
KR20120104803A (en) | Anti-bacterial compositions against fish pathogenic bacteria comprising extracts of terminaliachebula retzius, galla rhois and lemongrass | |
KR20120021844A (en) | Antibacterial compositions against fish disease bacteria | |
US7807201B2 (en) | Antifungal agent comprising natural plant extracts | |
Hasan-Al-Sharif et al. | Lemongrass (Cymbopogon Citratus) Essential Oil Improves Gut Health and Production Performance in Broiler: A Review | |
KR101904371B1 (en) | Composition for treating or preventing Acute Hepatopancreatic Necrosis Disease of Shrimp | |
KR20100079825A (en) | Antibiotic composition containing lily extract and preparation method of the same | |
Nithikulworawong | Antibacterial activity of Bauhinia sirindhorniae extract against Aeromonas hydrophila isolated from hybrid catfish | |
Halim et al. | Aqueous Morinda citrifolia Leaves Extract Enhancing Glutathione Peroxidase Activity and α2-Macroglobulin Gene Expression on Macrobrachium rosenbergii | |
KR100962236B1 (en) | Pig feed additive using natural pharmacologicl herb and igy and manufacturing method of that | |
Emmanuel et al. | Phytochemical screening, antioxidant and antimicrobial activities of the essential oils and ethanol extract of Psidium guajava Leaf | |
Chitra et al. | The use of ethnoveterinary medicine in treating cattle’s milking diseases | |
CN116531470B (en) | Multi-effect traditional Chinese medicine antibacterial agent and preparation method and application thereof | |
KR20130013965A (en) | Anti-fungal and anti-bacterial compositions against fish pathogenic bacteria | |
KR101339956B1 (en) | Anti-coccidial composition comprising herbal extracts | |
Wahyuningrum et al. | Preventive and curative effects of Phyllanthus niruri-Allium sativum combination on tiger grouper Epinephelus fuscoguttatus infected by Vibrio alginolyticus | |
Umaru et al. | Natural products, deforestation, and wildlife tourism could be a potential threat due to leptospirosis outbreak in Gashaka Gumti national park, and the in vitro antileptospiral activity of Annona senegalensis, its synergistic effects with commonly prescri | |
Pękala-Safińska et al. | Comparative assessment of the antibacterial efficacy of leaf extract obtained from Ficus benjamina L.(Moraceae) and its cultivars against Aeromonas sobria strain | |
KR102238139B1 (en) | Garlic skin fermented feeds using Rizofus strains and methods for manufacturing the same | |
KR102141462B1 (en) | Antibiotic composition containing extract of Acori Gramineri Rhizoma and extract of Magnoliae Cortex |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131230 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150529 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |